Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
University of Wisconsin, Madison Immunex Corporation |
---|---|
Information provided by: | University of Wisconsin, Madison |
ClinicalTrials.gov Identifier: | NCT00205231 |
This pilot study will investigate the safety and effect of etanercept in HIV infection by studying HIV replication and immune function (as measured by CD4 counts) in individuals with HIV infection.
Condition | Intervention |
---|---|
HIV Infections |
Drug: etanercept |
Study Type: | Interventional |
Study Design: | Non-Randomized, Open Label, Dose Comparison, Parallel Assignment |
Official Title: | A Pilot Study to Examine the Feasibility and Effect on Tumor Necrosis Factor (TNF) Inhibition on HIV Disease |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Inclusion Criteria:
Exclusion Criteria:
Subject has any of the following laboratory values within 30 days of baseline:
Contact: Andrew Urban, MD | 608-256-1901 ext 17472 | Andrew.Urban@med.va.gov |
Contact: Frank Graziano, MD, PhD | 608-263-6186 | fmg@medicine.wisc.edu |
United States, Wisconsin | |
University of Wisconsin Hospital and Clinics | Recruiting |
Madison, Wisconsin, United States, 53792 | |
Contact: Andrew Urban, MD 608-256-1901 ext 17472 andrew.urban@med.va.gov | |
Principal Investigator: Andrew Urban, MD |
Principal Investigator: | Andrew Urban, MD | University of Wisconsin Hospital and Clinics |
Study ID Numbers: | 2001-557 |
Study First Received: | September 13, 2005 |
Last Updated: | October 24, 2007 |
ClinicalTrials.gov Identifier: | NCT00205231 |
Health Authority: | United States: Food and Drug Administration |
HIV |
Virus Diseases Sexually Transmitted Diseases, Viral Necrosis HIV Infections Sexually Transmitted Diseases |
Acquired Immunodeficiency Syndrome TNFR-Fc fusion protein Retroviridae Infections Immunologic Deficiency Syndromes |
Anti-Inflammatory Agents RNA Virus Infections Slow Virus Diseases Immunologic Factors Immune System Diseases Physiological Effects of Drugs Gastrointestinal Agents Infection Immunosuppressive Agents Pharmacologic Actions |
Analgesics, Non-Narcotic Sensory System Agents Therapeutic Uses Lentivirus Infections Anti-Inflammatory Agents, Non-Steroidal Analgesics Peripheral Nervous System Agents Antirheumatic Agents Central Nervous System Agents |